PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Insomnia drug helps prevent oxycodone relapse, Scripps Research study shows

New findings suggest that treating insomnia can stop opioid-seeking behavior, even after ending treatment

2023-09-06
(Press-News.org) LA JOLLA, CA—A good night’s sleep has many proven health benefits, and a new Scripps Research study suggests one more: preventing opioid relapse.

In the new study, published online in Neuropharmacology on August 12, 2023, scientists gave an experimental insomnia treatment to rats experiencing oxycodone withdrawal. The researchers found that the animals were far less likely to seek out drugs again in the future—even after ending the treatment. These findings could eventually lead to therapies to help prevent opioid addiction or relapse in humans.

“These results are very encouraging,” says Rémi Martin-Fardon, PhD, associate professor of molecular medicine at Scripps Research and senior author of the study. “We hope in the future this compound may be useful for not only treating sleep disorders, but also drug use disorders.”

Opioids including oxycodone are used to treat pain, but carry a risk of misuse and opioid dependence in people who use them regularly. In 2021, opioid overdoses killed more than 80,000 people in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC).

Researchers know that during opioid withdrawal—which can last for days in people who are dependent on the drug—people experience a range of symptoms including nausea, vomiting, sweating, chills, pain, anxiety and insomnia.

Martin-Fardon and Jessica Illenberger, PhD, a postdoctoral research fellow at Scripps Research and first author of the study, wondered whether treating the insomnia associated with opioid withdrawal might help prevent relapse. This is why they turned to an experimental insomnia drug known as DORA-12, which is like the FDA-approved drug Belsomra (suvorexant).

“A lot of drug use and relapse are primarily motivated by a person’s desire to alleviate these withdrawal symptoms,” says Illenberger. “The idea behind testing this treatment was that if people or animals sleep better during that withdrawal period, then when they wake up, perhaps they won’t feel so much craving and won’t be as likely to relapse.”

In a previous study, the researchers found that suvorexant decreased the amount of oxycodone that opioid-dependent rats self-administered during binge sessions. In the new study, the team focused more on the withdrawal period from oxycodone.

During a 14-day withdrawal period from oxycodone, opioid-dependent rats showed expected withdrawal symptoms, including disturbed circadian rhythms like those seen in insomnia—marked by an increase in activity, eating and drinking during their usual sleeping hours. However, rats given DORA-12 during this withdrawal period showed patterns of behavior and physiological activities more like animals not dependent on opioids. In addition, when once again exposed to cues they had learned to associate with oxycodone, the rats treated with DORA-12 did not show drug-seeking behavior. Signs of opioid addiction in the brain, characterized by the number of certain neuron types, were also reversed by DORA-12, and the effect persisted even if DORA-12 had not been given for days.

Interestingly, Martin-Fardon’s group saw slightly different results between male and female animals. Although all rats had less opioid relapse when treated with DORA-12, the drug was less effective in female animals and the changes to neuron numbers seemed to be more pronounced in males.

“I think this is something really important to follow up on,” says Martin-Fardon. “It may be that women are much more sensitive to the effect of oxycodone and different doses of treatment are required.”

More studies are needed to show the utility of DORA-12 or similar insomnia drugs to treat opioid addiction in people. Already, clinical researchers at the Pearson Center for Alcohol and Addiction Research are studying the use of the insomnia drug suvorexant in people with alcohol use disorder.

In addition to Martin-Fardon and Illenberger, authors of the study, “Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement,” include Francisco Flores-Ramirez, Glenn Pascasio and Alessandra Matzeu of Scripps Research.

This work was supported by funding from the Merck Investigator Studies Program (MISP59371), NIH/NIAAA (AA026999, AA028549, AA006420, T32 AA0074560) and NIH/NIDA (DA053443). The DORA-12 was provided by Merck Pharmaceuticals

END


ELSE PRESS RELEASES FROM THIS DATE:

Disease affects blackbirds more than previously thought

2023-09-06
The researchers studied birds given a simulated bacterial infection in order to stimulate their immune system. The birds were then compared with birds whose immune system was not stimulated – and their activity was measured for several weeks using miniature data loggers. “We found that the birds whose immune system was stimulated had reduced activity for three weeks, which is much longer than we expected. We could also see that the "sick" blackbirds stopped their activities ...

The António Champalimaud Vision Award 2023 distinguishes St John of Jerusalem Eye Hospital for their fight against blindness in Palestine

2023-09-06
The 2023 edition of the António Champalimaud Vision Award recognizes the St John of Jerusalem Eye Hospital Group (SJEHG) for its work supporting hundreds of thousands of people living in the Gaza Strip, West Bank and East Jerusalem, helping in the fight against blindness while providing access to essential health services in a region marked by conflict and instability. The SJEHG has been developing its activity at the centre of three major world religions. The ongoing conflict in the region has had a severe impact on health care access and delivery. Without the intervention of the SJEHG, the rate of blindness would be rampant, increasing ...

CityU’s novel AI system enhances the predictive accuracy of autonomous driving

CityU’s novel AI system enhances the predictive accuracy of autonomous driving
2023-09-06
Precisive real-time prediction of the movement of nearby vehicles or the future trajectory of pedestrians is essential for safe autonomous driving. A research team led by City University of Hong Kong (CityU) recently developed a novel AI system that improves predictive accuracy amid dense traffic and increases computational efficiency by over 85%, offering great potential for enhancing the safety of autonomous vehicles. Professor Wang Jianping, in the Department of Computer Science (CS) at CityU, who led the study, explained the critical importance ...

Study finds association between being breastfed as an infant and risk of colorectal cancer as an adult

2023-09-06
Study Title: Being Breastfed in Infancy and Risk of Colorectal Cancer and Precursor Lesions Publication: Clinical Gastroenterology and Hepatology: https://www.cghjournal.org/article/S1542-3565(23)00673-0/fulltext Dana-Farber Cancer Institute authors include Chen Yuan, ScD, first author; Kimmie Ng, MD, MPH, senior author Summary: Rates of young-onset colorectal cancer have been on the rise since the early 1990s. This study, led by researchers at Dana-Farber Cancer Institute, investigated potential links between being breastfed as an infant and having colorectal cancer later in life. The team evaluated data collected by the Nurses’ Health Study ...

Study looking at how intermittent fasting and weight loss affect aging

Study looking at how intermittent fasting and weight loss affect aging
2023-09-06
Studies have shown that intermittent fasting can help people lose weight and may be easier to follow than counting calories to lose weight, such as traditional calorie restriction. Exciting new research in animals suggests that intermittent fasting slows aging and helps animals live longer. Researchers at the Pennington Biomedical Research Center and the University of Alabama at Birmingham are conducting a study to see if eating for 8 hours and fasting for 16 each day can slow the aging process in people and are looking for healthy adults aged 25-49 to participate. In this study, called DiAL-Health, researchers will ...

New global climate restoration fund announces first grant cycle

2023-09-06
[Bethesda, Maryland, USA  -- September 6] The new Climate Intervention Environmental Impact Fund (CIEIF, www.cieif.org) begins operations today, with the goal of helping kickstart new approaches to restoring Earth’s climate in the face of rapid deterioration.  CIEF makes direct grants to investigators worldwide working to stop and reverse global warming. The grants are focused on predictive environmental impact assessments, impact modeling studies, and stakeholder engagement for proposed small-scale field tests of innovative climate intervention technologies. CIEIF also offers investigators expert advice on ...

IU researchers identify new gene mutation that alters Alzheimer’s disease risk

2023-09-06
INDIANAPOLIS—A groundbreaking study led by experts from Indiana University School of Medicine has shed new light on the genetic underpinnings of Alzheimer's disease. The team's research, rooted in human genetics studies, has unearthed a critical mutation within a key gene operating in the brain's immune cells, potentially elevating the risk of Alzheimer's disease. The research team included several IU investigators within Stark Neurosciences Research Institute—Gary Landreth, PhD, the Martin Professor of Alzheimer’s Research; Bruce Lamb, PhD, executive director of Stark Neuroscience Research Institute; Stephanie Bissel, PhD, assistant ...

NIH investigates multidrug-resistant bacterium emerging in community settings

NIH investigates multidrug-resistant bacterium emerging in community settings
2023-09-06
New “hypervirulent” strains of the bacterium Klebsiella pneumoniae have emerged in healthy people in community settings, prompting a National Institutes of Health research group to investigate how the human immune system defends against infection. After exposing the strains to components of the human immune system in a laboratory “test tube” setting, scientists found that some strains were more likely to survive in blood and serum than others, and that neutrophils (white blood cells) are more likely to ingest and kill some strains than others. The study, published in mBio, was led by researchers at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). “This ...

Study reports discovery of new cell type in thymus

Study reports discovery of new cell type in thymus
2023-09-06
RIVERSIDE, Calif. -- It came as a surprise to Professor David Lo and his graduate student Diana Del Castillo when they were recently consulted by researchers in Israel for their expertise on specialized cells called Microfold cells, or M cells, which are mostly known for their presence in the intestinal epithelium. The Israeli group had identified similar cells in the thymus, an organ located just above the heart that makes lymphocytes — white blood cells that play an important role in the immune system and protect the body against infection. Lo, a distinguished professor of biomedical sciences in the UC Riverside School of Medicine, and Del Castillo, ...

Devices offers long-distance, low-power underwater communication

Devices offers long-distance, low-power underwater communication
2023-09-06
MIT researchers have demonstrated the first system for ultra-low-power underwater networking and communication, which can transmit signals across kilometer-scale distances. This technique, which the researchers began developing several years ago, uses about one-millionth the power that existing underwater communication methods use. By expanding their battery-free system’s communication range, the researchers have made the technology more feasible for applications such as aquaculture, coastal hurricane prediction, and climate change modeling. “What started as a very exciting ...

LAST 30 PRESS RELEASES:

NASA’s Parker Solar Probe makes history with closest pass to Sun

Are we ready for the ethical challenges of AI and robots?

Nanotechnology: Light enables an "impossibile" molecular fit

Estimated vaccine effectiveness for pediatric patients with severe influenza

Changes to the US preventive services task force screening guidelines and incidence of breast cancer

Urgent action needed to protect the Parma wallaby

Societal inequality linked to reduced brain health in aging and dementia

Singles differ in personality traits and life satisfaction compared to partnered people

President Biden signs bipartisan HEARTS Act into law

Advanced DNA storage: Cheng Zhang and Long Qian’s team introduce epi-bit method in Nature

New hope for male infertility: PKU researchers discover key mechanism in Klinefelter syndrome

Room-temperature non-volatile optical manipulation of polar order in a charge density wave

Coupled decline in ocean pH and carbonate saturation during the Palaeocene–Eocene Thermal Maximum

Unlocking the Future of Superconductors in non-van-der Waals 2D Polymers

Starlight to sight: Breakthrough in short-wave infrared detection

Land use changes and China’s carbon sequestration potential

PKU scientists reveals phenological divergence between plants and animals under climate change

Aerobic exercise and weight loss in adults

Persistent short sleep duration from pregnancy to 2 to 7 years after delivery and metabolic health

Kidney function decline after COVID-19 infection

Investigation uncovers poor quality of dental coverage under Medicare Advantage

Cooking sulfur-containing vegetables can promote the formation of trans-fatty acids

How do monkeys recognize snakes so fast?

Revolutionizing stent surgery for cardiovascular diseases with laser patterning technology

Fish-friendly dentistry: New method makes oral research non-lethal

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

[Press-News.org] Insomnia drug helps prevent oxycodone relapse, Scripps Research study shows
New findings suggest that treating insomnia can stop opioid-seeking behavior, even after ending treatment